LINC02295

Across TCGA pan-cancer cohorts, LINC02295 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of LINC02295’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where LINC02295 RNA is repressed in tumor relative to normal tissue. In most cancer types LINC02295 is over-expressed in tumor, although a few such as COAD and READ show the opposite, repressed pattern.

COAD, LUSC, and READ are the cancer types where LINC02295 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC02295 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	All	All	−0.140	<.001	4	view →
LUSC	All	II,III,IV	+0.248	.027	3	view →
READ	All	III,IV	−0.750	.014	2	view →
KIRC	All	All	+0.070	.001	2	view →
BRCA	Female	All	+0.053	.012	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

LINC02295–COAD

Open the COAD breakdown →